Renaissance Technologies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-240,927
Closed -$16.8M 4509
2022
Q3
$16.8M Sell
240,927
-27,373
-10% -$1.91M 0.02% 760
2022
Q2
$18M Buy
268,300
+174,300
+185% +$11.7M 0.02% 783
2022
Q1
$7.73M Buy
+94,000
New +$7.73M 0.01% 1297
2021
Q3
Sell
-41,907
Closed -$6.77M 3950
2021
Q2
$6.77M Sell
41,907
-47,993
-53% -$7.75M 0.01% 1442
2021
Q1
$15.4M Sell
89,900
-94,200
-51% -$16.1M 0.02% 926
2020
Q4
$40.4M Buy
+184,100
New +$40.4M 0.04% 427
2020
Q1
Sell
-62,100
Closed -$8M 3909
2019
Q4
$8M Sell
62,100
-293,800
-83% -$37.9M 0.01% 1586
2019
Q3
$27.7M Sell
355,900
-93,100
-21% -$7.25M 0.02% 783
2019
Q2
$46.2M Buy
449,000
+398,700
+793% +$41.1M 0.04% 526
2019
Q1
$3.69M Buy
50,300
+11,400
+29% +$836K ﹤0.01% 1999
2018
Q4
$1.65M Sell
38,900
-58,300
-60% -$2.47M ﹤0.01% 2336
2018
Q3
$4.58M Buy
97,200
+92,600
+2,013% +$4.36M ﹤0.01% 1862
2018
Q2
$227K Buy
+4,600
New +$227K ﹤0.01% 3046
2017
Q2
Sell
-164,302
Closed -$854K 3408
2017
Q1
$854K Buy
+164,302
New +$854K ﹤0.01% 2599
2016
Q4
Sell
-106,800
Closed -$706K 3521
2016
Q3
$706K Sell
106,800
-128,920
-55% -$852K ﹤0.01% 2705
2016
Q2
$1.29M Buy
+235,720
New +$1.29M ﹤0.01% 2423
2015
Q2
Sell
-23,900
Closed -$701K 3430
2015
Q1
$701K Buy
+23,900
New +$701K ﹤0.01% 2470
2014
Q2
Sell
-21,000
Closed -$400K 3030
2014
Q1
$400K Buy
+21,000
New +$400K ﹤0.01% 2427